TWD 29.65
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -40.03 Million TWD | -69.0% |
2022 | -23.68 Million TWD | -342.6% |
2021 | -5.35 Million TWD | 50.6% |
2020 | -10.83 Million TWD | 37.58% |
2019 | -17.35 Million TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -11.19 Million TWD | 2.53% |
2024 Q2 | -3.41 Million TWD | 69.53% |
2023 FY | -40.03 Million TWD | -69.0% |
2023 Q4 | -11.48 Million TWD | -20.77% |
2023 Q3 | -9.51 Million TWD | -59.83% |
2023 Q2 | -5.95 Million TWD | 54.54% |
2023 Q1 | -13.08 Million TWD | -9.63% |
2022 Q4 | -11.93 Million TWD | 0.0% |
2022 FY | -23.68 Million TWD | -342.6% |
2021 FY | -5.35 Million TWD | 50.6% |
2020 FY | -10.83 Million TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | 22.689% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 115.949% |
Level Biotechnology Inc. | 62.9 Million TWD | 163.64% |
Sagittarius Life Science Corp | -55.03 Million TWD | 27.264% |
NeoCore Technology Co., Ltd. | -64.64 Million TWD | 38.073% |
TaiMed Biologics Inc. | -194.81 Million TWD | 79.45% |
GlycoNex Incorporation | -178.36 Million TWD | 77.555% |
VBI | -6.6 Million TWD | -506.469% |
GeneReach Biotechnology Corp. | -166.27 Million TWD | 75.923% |
Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | -274.771% |
SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | -4.875% |
Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 76.18% |
Visgeneer Inc. | -19.58 Million TWD | -104.365% |
Mycenax Biotech Inc. | -682.84 Million TWD | 94.137% |
Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 106.398% |
G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 155.294% |
Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 96.548% |
TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | -562.031% |
Enimmune corporation | -223.74 Million TWD | 82.108% |
TaiRx, Inc. | -212.29 Million TWD | 81.142% |
CHO Pharma, Inc. | -306.08 Million TWD | 86.921% |
EirGenix Inc. | -915.2 Million TWD | 95.626% |
BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 180.48% |
Sunny Pharmtech Inc. | -63.32 Million TWD | 36.777% |
Lin BioScience, Inc. | -687.19 Million TWD | 94.174% |
BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 74.391% |
Feng Chi Biotech Corp. | 22.79 Million TWD | 275.645% |
Bio Preventive Medicine Corp. | -73.28 Million TWD | 45.374% |
Lukas Biomedical Inc. | -47.35 Million TWD | 15.458% |
RBC Bioscience Corporation | 6.43 Million TWD | 722.597% |
BiOptic Inc. | 37.74 Million TWD | 206.056% |
BRIM Biotechnology, Inc. | -688.02 Million TWD | 94.181% |
Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | -7.717% |
Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | 34.948% |
Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 114.567% |
Advagene Biopharma Co., Ltd. | -92.11 Million TWD | 56.538% |
NaviFUS Corp. | -65.72 Million TWD | 39.094% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | 54.554% |
Sinew Pharma Inc. | -170.92 Million TWD | 76.578% |
Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | 41.265% |
Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 130.638% |
Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 83.182% |
AP Biosciences Inc | -339.29 Million TWD | 88.201% |
Medigen Biotechnology Corp. | -561.29 Million TWD | 92.868% |
3D Global Biotech Inc. | -57.95 Million TWD | 30.919% |
Pharmosa Biopharm Inc. | 8.45 Million TWD | 573.427% |
Intech Biopharm Corporation | -337.98 Million TWD | 88.155% |
Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 96.951% |
Eusol Biotech Co.,Ltd. | -51.61 Million TWD | 22.436% |
TWi Biotechnology, Inc. | -170.68 Million TWD | 76.545% |
Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 107.422% |
TCI GENE Inc. | 11.67 Million TWD | 442.954% |
MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 68.613% |
Senhwa Biosciences, Inc. | -296.3 Million TWD | 86.489% |
Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 81.595% |
NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 495.583% |
PharmaEngine, Inc. | 274.65 Million TWD | 114.576% |
Savior Lifetec Corporation | 30.03 Million TWD | 233.31% |
TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 129.279% |
OBI Pharma, Inc. | -1.04 Billion TWD | 96.174% |
Meribank Biotech Co., Ltd | -125.34 Million TWD | 68.062% |
Acepodia, Inc. | -817.31 Million TWD | 95.102% |
Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 91.804% |